Next Previous
Read more about CREATHOR

Creathor Venture

European Venture Capital

»History does not repeat itself, but it does rhyme.«Mark Twain
Investments since 1984

Our team has proven itself as a responsible partner in over 200 investment projects, as the lead investor in 20 IPOs and in numerous trade sales since 1984. We are always excited about disruptive trends – but never get carried away by the hype. We are willing to take risks – without being overconfident. Our experience enables us to make decisions that enhance our companies’ success. We invest because we believe in extraordinary ideas and the people who make them a reality.

If you want to go far, go together.

We provide active support throughout every stage of development, from establishing a business to the initial public offering – as a sparring partner to a company’s executive board without intervening in day-to-day operations. We are a trustworthy partner to our businesses. Fairness, openness and respect are principles we stand by. We believe that it takes honest and open discussions to yield outstanding results.

Actions speak louder than words.

We are investors with an entrepreneurial mindset. After all, we do more than simply manage foreign capital. We place so much faith in our businesses that we have been the single largest investor in our companies: To date, the Creathor team has contributed approximately 25 % of all funds invested in our companies. We invest in every growth stage of a business with up to three million euro per financing round and around ten million euro per company. We assemble a syndicate of international co-investors for businesses with greater financing needs.

We are looking for more than ideas

We believe in teams and businesses with bold concepts, enthusiasm and the potential to develop into international market leaders. We invest in mobile, digital media, cloud technology, internet of things, sharing economy, fintech and in selected areas of the life science sector such as precision medicine, enabling platforms, medtech and digital health.

Subscribe to our newsletter and stay up to date with us!